FindTrial
Sign In

Influence of pain in the immune function and therapeutic effects of multiple myeloma patients

Influence of pain in the immune function and therapeutic effects of multiple myeloma patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000028951
Enrollment
Unknown
Registered
2020-01-09
Start date
2020-01-01
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

multiple myeloma

Interventions

acute pain group vs. chronic pain group:N/A

Sponsors

Affiliated Zhanjiang Central People's Hospital of Guangdong Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 90 Years

Inclusion criteria

Inclusion criteria: Multiple myeloma patients who have signed the consent form.

Exclusion criteria

Exclusion criteria: Patients with other immune diseases, pain caused by other diseases, other cancers, mental disease and contraindications of drugs in this study.

Design outcomes

Primary

MeasureTime frame
partial remission rate;—

Countries

China

Contacts

Public ContactBowan Huang

Affiliated Zhanjiang Central People's Hospital of Guangdong Medical University

285021731@qq.com+86 13760211733

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026